| Description | This product is a human antibody recognizing LCMV GP (Lymphocytic choriomeningitis virus surface glycoprotein), termed as 18.5C-M28. It locks the glycoprotein in the pre-fusion state to prevent viral entry. 18.5C-M28 neutralizes lymphocytic choriomeningitis virus in vitro and prophylactically and therapeutically protects mice from chronic LCMV infection. It has been tested by Enzyme-linked immunosorbent assay, Bio-layer interferometry and Neutralization assay. |
| Clonality | Monoclonal |
| Host Species | Human |
| Target Species | Lymphocytic choriomeningitis virus (LCMV) |
| Isotype | Human IgG |
| Expression Species | HEK293F or CHO cell line |
| Conjugation | Unconjugated |
| Purity | >95% |
| Endotoxin | <1 EU/mg |
| Form | Liquid |
| Purification | Protein A purified |
| Sterility | 0.2 μM filtered |
| Formulation | PBS, pH 7.4 |
| Preservation | No preservatives |
| Stabilizer | No stabilizers |
| Storage | Store at 4°C within one or two weeks. Store at -20°C for long term. Avoid repeated freeze/thaw cycles. Refer to the COA file for specifics. |
| Application | ELISA; BLI; Neut |
| ELISA | Enzyme-Linked Immunosorbent Assay Protocol |
| WB | Western Blot Protocol |
| FC | Flow Cytometry Protocol |
| Target | LCMV GP |
| Alternative Name | lymphocytic choriomeningitis virus glycoprotein |
| Research Area | Infectious Disease |
| Related Disease | severe birth defects |
